Public Health Agency of Canada
Symbol of the Government of Canada

E-mail this page





Canada Communicable Disease Report (CCDR)

Canada Communicable Disease Report (CCDR)

  • Subcribe now
  • RSS Feed PSS Feed
  • Advisory Committee Statements and Supplements to the CCDR

Monthly Issue

2003 - Volume 29


Volume 29-25, December 15, 2003

  • Index 2003

Volume 29-24, December 15, 2003

  • Update - surveillance of health care workers exposed to blood, body fluids and bloodborne pathogens in Canadian hospital settings: 1 April, 2000, to 31 March, 2002
  • Notifiable Diseases Summary

Volume 29-23, December 1, 2003

  • Estimates of HIV prevalence and incidence in Canada, 2002
  • MenomuneTM meningococcal vaccine update

Volume 29-22, November 15, 2003

  • Ontario's 2003 West Nile virus public education campaign: was anybody listening?
  • Update: adverse events following civilian smallpox vaccination - United States, 2003

Volume 29-21, November 1, 2003

  • First documented outbreak of Listeria monocytogenes in Quebec, 2002
  • New international coalition aims to expand global access to HIV/AIDS Treatment
  • Announcement

Volume 29-20, October 15, 2003

  • Using provincial client registries for selection of control subjects: lessons learned

Volume 29-19, October 1, 2003

  • The Internet, a simple and convenient tool in Chlamydia trachomatis screening of young people
  • Notifiable Diseases Summary

Volume 29-18, September 15, 2003

  • National Policy Conference on Antibiotic Resistance, 5-7 October, 2002: summary of proceedings
  • Antimicrobial resistance: a deadly burden no country can afford to ignore

Volume 29-17, September 1, 2003

  • Investigation of an outbreak of Legionnaires' disease in a hospital under construction: Ontario, September-October 2002

Volume 29-16, August 15, 2003

  • Human rabies, British Columbia – January 2003
  • Pediatric tuberculosis in Canada
  • Pneumococcal conjunctivitis at an elementary school – Maine, September 20-December 6, 2002

Volume 29-15, August 1, 2003

  • Outbreak(s) of Ebola hemorrhagic fever, Congo and Gabon, October 2001 to July 2002
  • Laboratory-acquired vaccinia infection
  • Erratum

Volume 29-14, July 15, 2003

  • A survey of the accuracy of malaria reporting by the laboratories in Ontario and British Columbia
  • Outbreak of Salmonella Enteritidis phage type 11b in the provinces of Alberta and Saskatchewan, June 2000
  • Erratum

Volume 29-13, July 1, 2003

  • Update: Severe acute respiratory syndrome - Toronto, 2003
  • First case of variant Creutzfeldt-Jakob Disease in Canada

Volume 29-12, June 15, 2003

  • Assessment of in-flight transmission of SARS - Results of contact tracing, Canada
  • Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections - Los Angeles County, California, 2002-2003
  • Clarification

Volume 29-11, June 1, 2003

  • Cluster of Severe Acute Respiratory Syndrome Cases Among Protected Health Care Workers - Toronto, April 2003
  • Modelling the costs and effects of a universal infant immunization program using conjugated pneumococcal vaccine in British Columbia

Volume 29-10, May 15, 2003

  • Pre-Release-Tuberculosis in Canada, 2001
  • Contact investigation of a case of pulmonary and larynegeal tuberculosis

Volume 29-09, May 1, 2003

  • The war against an unknown pathogen: rising to the SARS challenge
  • Rotavirus vaccines, an update
  • Update to the 2002 Canadian Immunization Guide

Volume 29-08, April 15, 2003

  • Preliminary Clinical Description of Severe Acute Respiratory Syndrome
  • Epidemiology, Clinical Presentation and Laboratory Investigation of Severe Acute Respiratory Syndrome (SARS) in Canada, March 2003
  • Announcement

Volume 29-07, April 1, 2003

  • Evaluation of Nova Scotia's hepatitis C risk notification program
  • Notifiable Diseases Summary

Volume 29-06, March 15, 2003

  • Influenza in Canada: 2001-2002 Season

Volume 29-05, March 1, 2003

  • Invasive pneumococcal infections among Canadian aboriginal children
  • The WHO European report confirms links between socioeconomic development and health

Volume 29-04, February 15, 2003

  • Prevalence and determinants of HIV-1 subtypes in Canada: enhancing routinely collected information through the Canadian HIV Strain and Drug Resistance Surveillance Program

Volume 29-03, February 1, 2003

  • Investigation of an E. coli O157:H7 outbreak in Brooks, Alberta, June-July 2002: the role of occult cases in the spread of infection within a daycare setting

Volume 29-02, January 15, 2003

  • Tuberculosis in Canada 2000: Executive Summary
  • Tuberculosis among the foreign-born in Canada
  • Notifiable Diseases Summary
  • Erratum
  • Announcement

Volume 29-01, January 1, 2003

  • Immunization Registry Progress - United States, 2002
  • Alcohol for hand hygiene: new comparative studies add to the evidence base
  • Public health abstracts - Alcohol-based hand disinfection to reduce hospital-acquired infections
  • Outbreak news: Nipah virus
 Top of Page

Advisory Committee Statements and Supplements to the CCDR

An Advisory Committee Statement (ACS)
Committee to Advise on Tropical Medicine and Travel (CATMAT)
Statement on motion Sickness
ACS-11 - 15 November 2003

An Advisory Committee Statement (ACS)
Committee to Advise on Tropical Medicine and Travel (CATMAT)
Poliomyelitis Vaccination for International Travellers
ACS-10 - 15 October 2003

An Advisory Committee Statement (ACS)
Committee to Advise on Tropical Medicine and Travel (CATMAT)
Statement on Ethics and Travel
ACS-9 - 1 October 2003

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Statement on the Recommended use of Pneumococcal Conjugate Vaccine: Addendum
ACS-8 - 15 September 2003

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Statement on the Recommended use of Monoclonal Anti-RSV Antibody (Palivizumab)
ACS-7 - 15 September 2003

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Supplementary Statement on Conjugate Meningococcal Vaccines
ACS-6 - 1 September 2003

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Prevention of Pertussis in Adolescents and Adults>
ACS-5 - 1 September 2003

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Statement on Influenza Vaccination for the 2003-2004 Season
ACS-4 - 15 August 2003

An Advisory Committee Statement (ACS)
Committee to Advise on Tropical Medicine and Travel (CATMAT)
Travel Statement on Jet Lag
ACS-3 - 1 April 2003

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Immunization Recommendations for Cochlear Implant Recipients
ACS-2 - 1 April 2003

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Statement on Thimerosal
ACS-1 - 1 March 2003


Proceedings of the CANADIAN NATIONAL IMMUNIZATION CONFERENCE
CCDR Volume 29S4, May 2003

National Consensus Conference on Pertussis
CCDR Volume 29S3, April 2003

Salmonella, Campylobacter, pathogenic E.coli and Shigella, from 1996 to 1999
CCDR Volume 29S1, March 2003

 Information on how to download PDF files

 Canada Communicable Disease Report Masthead

 Guidelines for Authors Contributing to the CCDR

 CCDR Author's Checklist